Skip to main content
OpenTrials

Clinical trial condition

Infection, Human Immunodeficiency Virus I

Explore clinical trials studying Infection, Human Immunodeficiency Virus I. Study availability and eligibility vary by location and protocol.

16 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Infection, Human Immunodeficiency Virus I trial results

Completed

48-Week Study Of GW433908 And Ritonavir Or GW433908 Alone, Twice Daily In Pediatric Patients With HIV Infection

NCT00089583

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +12 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Los Angeles, California, United States
  • GSK Investigational Site Oakland, California, United States
  • GSK Investigational Site Jacksonville, Florida, United States
View all 39 locations
View Trial Details
Completed

HIV-1 Infection Study of Once a Day Versus Twice a Day Protease Inhibitor in Antiretroviral Treatment Naive Adults

NCT00450580

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +15 more
Locations
  • GSK Investigational Site Antwerp, Belgium
  • GSK Investigational Site Brussels, Belgium
  • GSK Investigational Site Ghent, Belgium
  • GSK Investigational Site Besançon, France
View all 69 locations
View Trial Details
Completed

Induction/Simplification With Atazanavir + Ritonavir + Abacavir/Lamivudine Fixed-Dose Combination In HIV-1 Infection

NCT00440947

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +13 more
Locations
  • GSK Investigational Site Phoenix, Arizona, United States
  • GSK Investigational Site Long Beach, California, United States
  • GSK Investigational Site Los Angeles, California, United States
  • GSK Investigational Site Los Angeles, California, United States
View all 72 locations
View Trial Details
Completed

Prospective Epidemiological Study Of The Prevalence Of HLA-B*5701 In HIV-1 Infected Patients

NCT00481390

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +14 more
Locations
  • GSK Investigational Site Helsinki, Finland
  • GSK Investigational Site Dublin, Ireland
  • GSK Investigational Site Alkmaar, Netherlands
  • GSK Investigational Site Amsterdam, Netherlands
View all 20 locations
View Trial Details

Related conditions